InsidersTradesSigma
Intervacc AB: directors' dealings · Finland · FIN-FSA
FI:intervacc-abSE0009607252FI·FIN-FSAMcap 408M€Healthcare
Explore the full insider trade history of Intervacc AB, a listed issuer based in Finland. Shares are quoted on FI FI, under the oversight of FIN-FSA. Operating in the Healthcare sector, Intervacc AB has published 6 insider filings. Market capitalisation: €408.3m. The latest transaction was reported on 19 May 2026 (Purchase). Among the most active insiders: Carl Johan Dalsgaard. The full history is free.
6
Insider Decl.
0
Thresholds
€2m
6 ops.
Buy Volume
·
0 ops.
Sell Volume
Financial data
FY ended December 2025 · cache
1.20 €
Analyst consensus
1 analystsStrong buy
2.10 €Target 2.10 €(+75%)2.10 €
Income statement
Revenue20.1 M€
Gross profit−11.5 M€-57% margin
Net income−80.8 M€-402.3% margin
Valuation
PER (forward)-5.0x
P/Book1.7x
Balance sheet & cash
Market cap408.3 M€
Total debt108 k€
Free Cash Flow−66.9 M€
Debt / Equity0%
Profitability & ownership
ROE-30.0%
ROA-18.0%
% insiders19.3%
% institutions34.4%
Last declaration on 19 May 2026
Declarations6 total
Executives●Purchase30FIN-FSA
€2m150,000 shares@ €12.54360.46% mcap99.2% of flow
Aktie
FI:A003Y813-1·
Ideal exit: 13 Feb 2027 (T+270)
Executives●Purchase31FIN-FSA
€11,598200,000 shares@ €0.0580.0028% mcap35.4% of flow
Aktie
FI:A003W618-1·
Ideal exit: 24 Nov 2026 (T+270)
Executives●Purchase24FIN-FSA
€8,923130,000 shares@ €0.06860.0022% mcap100.0% of flow
Aktie
FI:A003W620-1·
Ideal exit: 15 Nov 2026 (T+270)
Executives●Purchase29FIN-FSA
€7,019100,000 shares@ €0.07020.0017% mcap21.5% of flow
Aktie
FI:A003W345-1·
Ideal exit: 17 Nov 2026 (T+270)
Executives●Purchase31FIN-FSA
€14,103200,000 shares@ €0.07050.0035% mcap43.1% of flow
Aktie
FI:A003W152-1·
Ideal exit: 15 Nov 2026 (T+270)
Executives●Purchase20FIN-FSA
€15,917180,000 shares@ €0.08840.0039% mcap100.0% of flow
Aktie
FI:A003Q915-1·
Ideal exit: 17 Apr 2026 (T+270)
6 of 6 declarations